Acumen Pharmaceuticals Ownership 2024 | Who Owns Acumen Pharmaceuticals Now?
Institutional Ownership
38.81%
Insider Ownership
11.24%
Retail Ownership
49.96%
Institutional Holders
64.00
Acumen Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 24.96% | 0.48% | 14,932,063 | - | - | 36,135,592 | Jun 30, 2024 |
| SANDS CAPITAL VENTURES, LLC | 5.71% | 2.77% | 3,417,075 | - | - | 8,269,322 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 5.63% | 0.00% | 3,367,618 | -27,800 | -0.82% | 8,149,636 | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 3.85% | 0.17% | 2,300,059 | - | - | 5,566,143 | Jun 30, 2024 |
| BLACKROCK INC. | 3.61% | 0.00% | 2,158,661 | 1,968,964 | 1037.95% | 5,223,959 | Jun 30, 2024 |
| FMR LLC | 3.38% | 0.00% | 2,022,103 | -66,897 | -3.20% | 4,893,489 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 3.27% | 0.00% | 1,954,085 | -675,456 | -25.69% | 4,728,886 | Jun 30, 2024 |
| VANGUARD GROUP INC | 3.17% | 0.00% | 1,896,949 | 231,891 | 13.93% | 4,590,616 | Jun 30, 2024 |
| KNOLLWOOD INVESTMENT ADVISORY, LLC | 2.72% | 0.44% | 1,628,510 | - | - | 3,940,994 | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | 1.97% | 0.03% | 1,178,338 | -716,685 | -37.82% | 2,851,578 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.75% | 0.00% | 1,046,364 | -51,912 | -4.73% | 2,533,000 | Jun 30, 2024 |
| ALYESKA INVESTMENT GROUP, L.P. | 1.57% | 0.01% | 939,603 | - | - | 2,273,839 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.36% | 0.00% | 812,133 | 526,994 | 184.82% | 1,965,534 | Jun 30, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | 1.12% | 0.01% | 670,000 | 110,000 | 19.64% | 1,621,400 | Jun 30, 2024 |
| PATHSTONE HOLDINGS, LLC | 0.80% | 0.01% | 480,223 | 42 | 0.01% | 1,162,140 | Jun 30, 2024 |
| STATE STREET CORP | 0.73% | - | 436,565 | 354,787 | 433.84% | 1,056,487,000 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.57% | 0.00% | 338,100 | 338,100 | 100.00% | 818,202 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.52% | 0.00% | 310,797 | 132,896 | 74.70% | 752,129 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 0.45% | 0.11% | 266,435 | - | - | 644,774 | Jun 30, 2024 |
| TD ASSET MANAGEMENT INC | 0.25% | 0.00% | 148,800 | - | - | 360,096 | Jun 30, 2024 |
Acumen Pharmaceuticals's largest institutional shareholder is RA CAPITAL MANAGEMENT, L.P., holding 24.96% of the company's total share outstanding, currently valued at $36.14M. The top 10 institutional shareholders own together 58.28% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SANDS CAPITAL VENTURES, LLC | 5.71% | 2.77% | 3,417,075 | - | - | 8,269,322 | Jun 30, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 24.96% | 0.48% | 14,932,063 | - | - | 36,135,592 | Jun 30, 2024 |
| KNOLLWOOD INVESTMENT ADVISORY, LLC | 2.72% | 0.44% | 1,628,510 | - | - | 3,940,994 | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 3.85% | 0.17% | 2,300,059 | - | - | 5,566,143 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 0.45% | 0.11% | 266,435 | - | - | 644,774 | Jun 30, 2024 |
| CATALYST FINANCIAL PARTNERS LLC | 0.15% | 0.05% | 89,699 | - | - | 217,072 | Jun 30, 2024 |
| OXFORD ASSET MANAGEMENT LLP | 0.03% | 0.04% | 15,304 | 15,304 | 100.00% | 37,036 | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | 1.97% | 0.03% | 1,178,338 | -716,685 | -37.82% | 2,851,578 | Jun 30, 2024 |
| INTREPID FINANCIAL PLANNING GROUP LLC | 0.05% | 0.03% | 30,150 | - | - | 72,963 | Jun 30, 2024 |
| MURCHINSON LTD. | 0.09% | 0.02% | 56,250 | 56,250 | 100.00% | 136,125 | Jun 30, 2024 |
| ALYESKA INVESTMENT GROUP, L.P. | 1.57% | 0.01% | 939,603 | - | - | 2,273,839 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.25% | 0.01% | 148,400 | - | - | 359,128 | Jun 30, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 0.08% | 0.01% | 46,410 | 9,410 | 25.43% | 112,312 | Jun 30, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | 1.12% | 0.01% | 670,000 | 110,000 | 19.64% | 1,621,400 | Jun 30, 2024 |
| PATHSTONE HOLDINGS, LLC | 0.80% | 0.01% | 480,223 | 42 | 0.01% | 1,162,140 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.14% | 0.00% | 85,458 | 33,750 | 65.27% | 206,808 | Jun 30, 2024 |
| MARATHON TRADING INVESTMENT MANAGEMENT LLC | 0.04% | 0.00% | 26,298 | -33,702 | -56.17% | 63,641 | Jun 30, 2024 |
| PINNACLE WEALTH MANAGEMENT ADVISORY GROUP, LLC | 0.03% | 0.00% | 18,020 | - | - | 43,608 | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | 0.04% | 0.00% | 24,402 | 24,402 | 100.00% | 59,000 | Jun 30, 2024 |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 0.10% | 0.00% | 62,518 | - | - | 151,294 | Jun 30, 2024 |
The largest Acumen Pharmaceuticals shareholder by % of total assets is SANDS CAPITAL VENTURES, LLC. The company owns 3.42M shares of Acumen Pharmaceuticals (ABOS), representing 2.77% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 3.61% | 0.00% | 2,158,661 | 1,968,964 | 1037.95% | 5,223,959 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.36% | 0.00% | 812,133 | 526,994 | 184.82% | 1,965,534 | Jun 30, 2024 |
| STATE STREET CORP | 0.73% | - | 436,565 | 354,787 | 433.84% | 1,056,487,000 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.57% | 0.00% | 338,100 | 338,100 | 100.00% | 818,202 | Jun 30, 2024 |
| VANGUARD GROUP INC | 3.17% | 0.00% | 1,896,949 | 231,891 | 13.93% | 4,590,616 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.52% | 0.00% | 310,797 | 132,896 | 74.70% | 752,129 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.21% | 0.00% | 126,422 | 126,422 | 100.00% | 305,941 | Jun 30, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | 1.12% | 0.01% | 670,000 | 110,000 | 19.64% | 1,621,400 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.18% | 0.00% | 108,743 | 108,743 | 100.00% | 263,158 | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | 0.21% | 0.00% | 125,024 | 96,987 | 345.93% | 302,558,000 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.09% | - | 56,664 | 56,664 | 100.00% | 137,127 | Jun 30, 2024 |
| MURCHINSON LTD. | 0.09% | 0.02% | 56,250 | 56,250 | 100.00% | 136,125 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.09% | 0.00% | 55,007 | 55,007 | 100.00% | 133,117 | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.09% | 0.00% | 52,323 | 52,323 | 100.00% | 126,617 | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | 0.07% | 0.00% | 42,400 | 42,400 | 100.00% | 103,000 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.21% | - | 122,725 | 42,109 | 52.23% | 296,995 | Jun 30, 2024 |
| MORGAN STANLEY | 0.15% | - | 87,809 | 39,097 | 80.26% | 212,498 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.14% | 0.00% | 85,458 | 33,750 | 65.27% | 206,808 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 0.06% | - | 33,649 | 33,649 | 100.00% | 81,431 | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | 0.08% | 0.00% | 49,367 | 25,416 | 106.12% | 119,468 | Jun 30, 2024 |
As of Jun 30 2024, Acumen Pharmaceuticals's largest institutional buyer is BLACKROCK INC.. The company purchased 1.97M stocks of ABOS, valued at $5.22M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| LAURION CAPITAL MANAGEMENT LP | 1.97% | 0.03% | 1,178,338 | -716,685 | -37.82% | 2,851,578 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 3.27% | 0.00% | 1,954,085 | -675,456 | -25.69% | 4,728,886 | Jun 30, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | - | - | - | -576,657 | -100.00% | - | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.12% | 0.00% | 73,619 | -384,865 | -83.94% | 178,157 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.09% | - | 51,052 | -266,852 | -83.94% | 123,546 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | - | - | - | -246,895 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -113,232 | -100.00% | - | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | - | - | - | -112,258 | -100.00% | - | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -105,117 | -100.00% | - | Jun 30, 2024 |
| NEW YORK LIFE INVESTMENT MANAGEMENT LLC | - | - | - | -95,089 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.13% | 0.00% | 75,869 | -91,719 | -54.73% | 183,603 | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -89,707 | -100.00% | - | Jun 30, 2024 |
| MAN GROUP PLC | 0.18% | 0.00% | 105,777 | -81,808 | -43.61% | 255,980 | Jun 30, 2024 |
| FMR LLC | 3.38% | 0.00% | 2,022,103 | -66,897 | -3.20% | 4,893,489 | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -63,949 | -100.00% | - | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | - | - | - | -56,369 | -100.00% | - | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.03% | - | 17,877 | -54,013 | -75.13% | 60,067 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.75% | 0.00% | 1,046,364 | -51,912 | -4.73% | 2,533,000 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | - | - | - | -37,191 | -100.00% | - | Jun 30, 2024 |
| MARATHON TRADING INVESTMENT MANAGEMENT LLC | 0.04% | 0.00% | 26,298 | -33,702 | -56.17% | 63,641 | Jun 30, 2024 |
As of Jun 30 2024, Acumen Pharmaceuticals's biggest institutional seller is LAURION CAPITAL MANAGEMENT LP. The company sold -0.72M shares of ABOS, valued at $2.85M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 0.57% | 0.00% | 338,100 | 338,100 | 100.00% | 818,202 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.21% | 0.00% | 126,422 | 126,422 | 100.00% | 305,941 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.18% | 0.00% | 108,743 | 108,743 | 100.00% | 263,158 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.09% | - | 56,664 | 56,664 | 100.00% | 137,127 | Jun 30, 2024 |
| MURCHINSON LTD. | 0.09% | 0.02% | 56,250 | 56,250 | 100.00% | 136,125 | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.09% | 0.00% | 52,323 | 52,323 | 100.00% | 126,617 | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | 0.07% | 0.00% | 42,400 | 42,400 | 100.00% | 103,000 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 0.06% | - | 33,649 | 33,649 | 100.00% | 81,431 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.04% | 0.00% | 22,567 | 22,567 | 100.00% | 54,838 | Jun 30, 2024 |
| INVESCO LTD. | 0.03% | - | 18,986 | 18,986 | 100.00% | 45,946 | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | 0.03% | 0.00% | 18,801 | 18,801 | 100.00% | 45,498 | Jun 30, 2024 |
| OXFORD ASSET MANAGEMENT LLP | 0.03% | 0.04% | 15,304 | 15,304 | 100.00% | 37,036 | Jun 30, 2024 |
| ENGINEERS GATE MANAGER LP | 0.02% | 0.00% | 11,479 | 11,479 | 100.00% | 27,779 | Jun 30, 2024 |
| GLADIUS CAPITAL MANAGEMENT LP | 0.02% | 0.00% | 10,939 | 10,939 | 100.00% | 26,473 | Jun 30, 2024 |
| AMERITAS INVESTMENT PARTNERS, INC. | 0.01% | 0.00% | 4,110 | 4,110 | 100.00% | 9,946 | Jun 30, 2024 |
| POINT72 (DIFC) LTD | 0.01% | 0.00% | 4,018 | 4,018 | 100.00% | 9,724 | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | 0.01% | - | 3,635 | 3,635 | 100.00% | 8,797 | Jun 30, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 0.01% | - | 3,039 | 3,039 | 100.00% | 7,354 | Jun 30, 2024 |
| AMALGAMATED BANK | 0.00% | - | 1,451 | 1,451 | 100.00% | 4,000 | Jun 30, 2024 |
| REDWOOD WEALTH MANAGEMENT GROUP, LLC | 0.00% | 0.00% | 800 | 800 | 100.00% | 1,936 | Jun 30, 2024 |
| PLANNING CAPITAL MANAGEMENT CORP | - | - | 5 | 5 | 100.00% | 13 | Jun 30, 2024 |
Acumen Pharmaceuticals's largest new institutional shareholder by number of shares is RENAISSANCE TECHNOLOGIES LLC, purchased 338.10K shares, valued at $818.20K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PARKMAN HEALTHCARE PARTNERS LLC | - | - | - | -576,657 | -100.00% | - | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | - | - | - | -246,895 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -113,232 | -100.00% | - | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | - | - | - | -112,258 | -100.00% | - | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -105,117 | -100.00% | - | Jun 30, 2024 |
| NEW YORK LIFE INVESTMENT MANAGEMENT LLC | - | - | - | -95,089 | -100.00% | - | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -89,707 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -63,949 | -100.00% | - | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | - | - | - | -56,369 | -100.00% | - | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | - | - | - | -37,191 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | - | - | - | -27,556 | -100.00% | - | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | - | - | - | -25,620 | -100.00% | - | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -25,370 | -100.00% | - | Jun 30, 2024 |
| OMERS ADMINISTRATION CORP | - | - | - | -23,800 | -100.00% | - | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | - | - | - | -19,000 | -100.00% | - | Jun 30, 2024 |
| CHICAGO PARTNERS INVESTMENT GROUP LLC | - | - | - | -13,958 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -12,856 | -100.00% | - | Jun 30, 2024 |
| ALGERT GLOBAL LLC | - | - | - | -12,410 | -100.00% | - | Jun 30, 2024 |
| LMR PARTNERS LLP | - | - | - | -11,503 | -100.00% | - | Jun 30, 2024 |
| CTC ALTERNATIVE STRATEGIES, LTD. | - | - | - | -11,100 | -100.00% | - | Jun 30, 2024 |
| INTEGRATED WEALTH CONCEPTS LLC | - | - | - | -10,100 | -100.00% | - | Jun 30, 2024 |
| MACQUARIE GROUP LTD | - | - | - | -1,247 | -100.00% | - | Jun 30, 2024 |
Acumen Pharmaceuticals's largest sold out institutional shareholder by shares sold is PARKMAN HEALTHCARE PARTNERS LLC, sold -0.58M shares, valued at -, as of undefined.
Acumen Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| BlackRock Health Sciences Trust | 0.61% | 152,651 | - | - | Mar 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.22% | 1,874,300 | 182,100 | 10.76% | Jan 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.07% | 600,000 | 600,000 | - | Jan 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.06% | 143,000 | 33,367 | 30.44% | Mar 28, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND IV | 0.05% | 140,000 | 140,000 | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.05% | 26,300 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust II | 0.03% | 78,892 | - | - | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.02% | 1,000,000 | 998,500 | 66566.67% | Feb 29, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 3,876 | - | - | Mar 31, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.01% | 57,936 | - | - | Mar 28, 2024 |
| Fidelity Central Investment Portfolios LLC | 0.01% | 280,000 | 280,000 | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 1,618,488 | -644,985 | -28.50% | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND | 0.00% | 69,000 | 69,000 | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.00% | 14,760 | - | - | Mar 31, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 103,254 | - | - | Feb 29, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 257,899 | 11,645 | 4.73% | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 2,205 | - | - | Mar 31, 2024 |
| BlackRock ETF Trust | 0.00% | 668 | - | - | Jan 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 13,586 | -1,681 | -11.01% | Mar 31, 2024 |
| RBB FUND, INC. | 0.00% | 38,220 | - | - | Feb 29, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 8,535 | - | - | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,301 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 27,305 | 7,970 | 41.22% | Feb 29, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 9,845 | - | - | Jan 31, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 21,110 | - | - | Mar 28, 2024 |
| Global X Funds | 0.00% | 8,206 | - | - | Jan 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 3,641 | - | - | Mar 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 772,313 | - | - | Mar 28, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 5,400 | - | - | Mar 31, 2024 |
| FLEXSHARES TRUST | 0.00% | 5,264 | - | - | Jan 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 229,498 | - | - | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 222 | - | - | Dec 31, 2023 |
| ProFunds | 0.00% | 605 | - | - | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 95,897 | - | - | Feb 29, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 6,265 | 6,002 | 2282.13% | Jan 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 1,200 | - | - | Mar 28, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 862 | - | - | Feb 29, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 148 | - | - | Dec 31, 2023 |
| VALIC Co I | 0.00% | 10,487 | - | - | Feb 29, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 3,970 | - | - | Mar 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 149 | - | - | Feb 29, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 5,395 | 563 | 11.65% | Jan 31, 2024 |
| VANGUARD QUANTITATIVE FUNDS | 0.00% | 100 | - | - | Mar 31, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 2,400 | 1,500 | 166.67% | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 20,085 | -23,653 | -54.08% | Jan 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,554 | - | - | Feb 29, 2024 |
| PROSHARES TRUST | 0.00% | 3,691 | - | - | Feb 29, 2024 |
| EQ ADVISORS TRUST | 0.00% | 17,218 | 10,700 | 164.16% | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 6,202 | -2,194 | -26.13% | Jan 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 39,241 | - | - | Mar 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 33,055 | - | - | Mar 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 10 | - | - | Dec 31, 2023 |
| SUNAMERICA SERIES TRUST | 0.00% | 3,120 | - | - | Mar 31, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 23,332 | - | - | Dec 31, 2023 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 16,996 | 13,121 | 338.61% | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 1,062 | - | - | Mar 28, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 7,209 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 85,632 | -1,539 | -1.77% | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 68 | - | - | Jan 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 975 | - | - | Jan 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 2,227 | - | - | Dec 31, 2023 |
| Advisors' Inner Circle Fund III | 0.00% | 138 | 138 | - | Jan 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 2,758 | - | - | Mar 31, 2024 |
| Bridge Builder Trust | 0.00% | 4,274 | - | - | Mar 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 3,660 | - | - | Feb 29, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 7,340 | - | - | Feb 29, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 1,128 | - | - | Mar 31, 2024 |
| John Hancock Funds II | 0.00% | 3,183 | 3,183 | - | Feb 29, 2024 |
Acumen Pharmaceuticals's largest mutual fund holder by % of total assets is "BlackRock Health Sciences Trust", owning 152.65K shares, compromising 0.61% of its total assets.
Acumen Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 64 | -23.81% |
| 31 Mar, 24 | 84 | 16.67% |
| 31 Dec, 23 | 72 | -1.37% |
| 30 Sep, 23 | 73 | 23.73% |
| 30 Jun, 23 | 59 | -9.23% |
| 31 Mar, 23 | 65 | - |
| 31 Dec, 22 | 65 | 16.07% |
| 30 Sep, 22 | 56 | 21.74% |
| 30 Jun, 22 | 46 | -17.86% |
| 31 Mar, 22 | 56 | 9.80% |
| 31 Dec, 21 | 51 | 24.39% |
| 30 Sep, 21 | 41 | - |
As of 30 Jun 24, 64 institutions are holding Acumen Pharmaceuticals's shares, representing a decrease of -23.81% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 23,211,550 | -46.48% |
| 31 Mar, 24 | 43,366,076 | 12.88% |
| 31 Dec, 23 | 38,419,207 | -11.04% |
| 30 Sep, 23 | 43,186,726 | 63.99% |
| 30 Jun, 23 | 26,334,754 | -5.21% |
| 31 Mar, 23 | 27,781,645 | -3.47% |
| 31 Dec, 22 | 28,781,179 | 4.63% |
| 30 Sep, 22 | 27,507,913 | 7.33% |
| 30 Jun, 22 | 25,628,763 | -5.47% |
| 31 Mar, 22 | 27,111,775 | 5.96% |
| 31 Dec, 21 | 25,587,867 | 6.39% |
| 30 Sep, 21 | 24,050,168 | - |
Acumen Pharmaceuticals (ABOS) has 23.21M shares outstanding as of 30 Jun 24, down -46.48% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 38.81% | 0.69% |
| 31 Mar, 24 | 74.88% | 1.49% |
| 31 Dec, 23 | 70.85% | 0.64% |
| 30 Sep, 23 | 105.27% | 2.55% |
| 30 Jun, 23 | 64.19% | 1.40% |
| 31 Mar, 23 | 67.72% | 1.35% |
| 31 Dec, 22 | 70.89% | 1.54% |
| 30 Sep, 22 | 67.92% | 1.70% |
| 30 Jun, 22 | 63.29% | 1.41% |
| 31 Mar, 22 | 66.99% | 1.50% |
| 31 Dec, 21 | 66.87% | 1.69% |
| 30 Sep, 21 | 62.85% | - |
As of 30 Jun 24, Acumen Pharmaceuticals is held by 38.81% institutional shareholders, representing a 0.69% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 39 | -20.41% |
| 31 Mar, 24 | 49 | 4.26% |
| 31 Dec, 23 | 47 | - |
| 30 Sep, 23 | 47 | 113.64% |
| 30 Jun, 23 | 22 | -24.14% |
| 31 Mar, 23 | 29 | -21.62% |
| 31 Dec, 22 | 37 | 8.82% |
| 30 Sep, 22 | 34 | 70.00% |
| 30 Jun, 22 | 20 | -50.00% |
| 31 Mar, 22 | 40 | 14.29% |
| 31 Dec, 21 | 35 | -14.63% |
| 30 Sep, 21 | 41 | - |
39 institutional shareholders have increased their position in ABOS stock as of 30 Jun 24 compared to 49 in the previous quarter (a -20.41% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 12 | -45.45% |
| 31 Mar, 24 | 22 | 144.44% |
| 31 Dec, 23 | 9 | -18.18% |
| 30 Sep, 23 | 11 | -45.00% |
| 30 Jun, 23 | 20 | -4.76% |
| 31 Mar, 23 | 21 | 16.67% |
| 31 Dec, 22 | 18 | 63.64% |
| 30 Sep, 22 | 11 | -42.11% |
| 30 Jun, 22 | 19 | 137.50% |
| 31 Mar, 22 | 8 | 33.33% |
| 31 Dec, 21 | 6 | - |
| 30 Sep, 21 | - | - |
12 institutional shareholders have reduced their position in ABOS stock as of 30 Jun 24 compared to 22 in the previous quarter (a -45.45% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 64 | -23.81% | 23,211,550 | -46.48% | 38.81% | 0.69% | 39 | -20.41% | 12 | -45.45% |
| 31 Mar, 24 | 84 | 16.67% | 43,366,076 | 12.88% | 74.88% | 1.49% | 49 | 4.26% | 22 | 144.44% |
| 31 Dec, 23 | 72 | -1.37% | 38,419,207 | -11.04% | 70.85% | 0.64% | 47 | - | 9 | -18.18% |
| 30 Sep, 23 | 73 | 23.73% | 43,186,726 | 63.99% | 105.27% | 2.55% | 47 | 113.64% | 11 | -45.00% |
| 30 Jun, 23 | 59 | -9.23% | 26,334,754 | -5.21% | 64.19% | 1.40% | 22 | -24.14% | 20 | -4.76% |
| 31 Mar, 23 | 65 | - | 27,781,645 | -3.47% | 67.72% | 1.35% | 29 | -21.62% | 21 | 16.67% |
| 31 Dec, 22 | 65 | 16.07% | 28,781,179 | 4.63% | 70.89% | 1.54% | 37 | 8.82% | 18 | 63.64% |
| 30 Sep, 22 | 56 | 21.74% | 27,507,913 | 7.33% | 67.92% | 1.70% | 34 | 70.00% | 11 | -42.11% |
| 30 Jun, 22 | 46 | -17.86% | 25,628,763 | -5.47% | 63.29% | 1.41% | 20 | -50.00% | 19 | 137.50% |
| 31 Mar, 22 | 56 | 9.80% | 27,111,775 | 5.96% | 66.99% | 1.50% | 40 | 14.29% | 8 | 33.33% |
| 31 Dec, 21 | 51 | 24.39% | 25,587,867 | 6.39% | 66.87% | 1.69% | 35 | -14.63% | 6 | - |
| 30 Sep, 21 | 41 | - | 24,050,168 | - | 62.85% | - | 41 | - | - | - |
Acumen Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Acumen Pharmaceuticals's stock was made by OConnell Daniel Joseph on Jan 19 2024, selling 15,200 shares at $3.47 per share (valued at $52.75K).
Acumen Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 7 | - | - |
| Q1 2024 | 11 | 5 | 220.00% |
| Q3 2023 | 3 | 4 | 75.00% |
| Q2 2023 | 6 | 1 | 600.00% |
| Q1 2023 | 11 | - | - |
| Q4 2022 | 1 | 1 | 100.00% |
| Q3 2022 | 2 | - | - |
| Q2 2022 | 14 | - | - |
| Q1 2022 | 4 | - | - |
| Q4 2021 | 1 | 1 | 100.00% |
| Q3 2021 | 24 | 16 | 150.00% |
| Q2 2021 | 5 | 24 | 20.83% |
| Q1 2008 | 2 | - | - |
| Q3 2007 | 2 | - | - |
| Q2 2007 | 1 | - | - |
| Q1 2007 | 4 | - | - |
| Q4 2006 | 4 | - | - |
| Q3 2006 | 1 | - | - |
| Q2 2006 | 1 | - | - |
| Q1 2006 | 6 | - | - |
7 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Acumen Pharmaceuticals's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | - | - |
| Q1 2024 | - | 5 | - |
| Q3 2023 | 1 | 2 | 50.00% |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q4 2022 | - | - | - |
| Q3 2022 | - | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | - | - |
| Q3 2021 | 8 | - | - |
| Q2 2021 | - | - | - |
| Q1 2008 | - | - | - |
| Q3 2007 | - | - | - |
| Q2 2007 | - | - | - |
| Q1 2007 | - | - | - |
| Q4 2006 | - | - | - |
| Q3 2006 | 1 | - | - |
| Q2 2006 | 1 | - | - |
| Q1 2006 | - | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Acumen Pharmaceuticals's stocks.
ABOS Ownership FAQ
Who Owns Acumen Pharmaceuticals?
Acumen Pharmaceuticals is owned by institutional shareholders (38.81%), insiders (11.24%), and public (49.96%). The largest institutional shareholder of Acumen Pharmaceuticals is RA CAPITAL MANAGEMENT, L.P. (24.96% of total shares) and the top mutual fund owner is BlackRock Health Sciences Trust (0.61% of total shares).
Who are the major institutional shareholders of Acumen Pharmaceuticals?
Acumen Pharmaceuticals's major institutional shareholders are RA CAPITAL MANAGEMENT, L.P., SANDS CAPITAL VENTURES, LLC, FRANKLIN RESOURCES INC, ROCK SPRINGS CAPITAL MANAGEMENT LP, and BLACKROCK INC.. The top five shareholders own together 43.76% of the company's share outstanding.
How many Acumen Pharmaceuticals shareholders are there?
As of Jun 2024, there are 64 institutional shareholders of Acumen Pharmaceuticals.
What percentage of Acumen Pharmaceuticals is owned by RA CAPITAL MANAGEMENT, L.P?
RA CAPITAL MANAGEMENT, L.P owns 14.93M shares of Acumen Pharmaceuticals, representing 24.96% of the company's total shares outstanding, valued at $36.14M (as of Jun 2024).
What percentage of Acumen Pharmaceuticals is owned by SANDS CAPITAL VENTURES, LLC?
As of Jun 2024, SANDS CAPITAL VENTURES, LLC holds 3.42M shares of Acumen Pharmaceuticals (ABOS), compromising 5.71% of the company, valued at $8.27M.
What percentage of Acumen Pharmaceuticals is owned by FRANKLIN RESOURCES INC?
FRANKLIN RESOURCES INC is the third largest holder of Acumen Pharmaceuticals. The company owns 3.37M of the company's shares outstanding (worth $8.15M).